Intercell has successfully completed its combined primary and secondary offering of its common stock.The offering consisted of a public offering in Austria and a private placement to institutional investors outside of Austria.The offer price was set at euro 12.36 per share,resulting in gross proceeds of euro 58.5 million to Intercell with 4,736,835 primary shares sold.Intercell intends to use the net proceeds of this offe ring for further organic growth of its promising vaccine pipeline,expansion of its ma nufacturing capacities and general corporate purposes.
展开▼